AGRX — Agile Therapeutics Share News
0.000.00%
Last trade - 00:00- $10.43m
- $7.58m
- $19.59m
U.S. STOCKS ON THE MOVE-Athenex, Tupperware Brands, Chiasma
Agile Therapeutics slips after bigger Q1 loss
Agile Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Agile Therapeutics Q1 Net Loss $0.20 Per Share
Brief: Agile Therapeutics Entered Into A Common Stock Sales Agreement
Brief: Agile Therapeutics Reports Q4 Loss Per Share Of $0.20
Brief: Agile Therapeutics Says Cash, Cash Equivalents And Marketable Securities Sufficient To Meet Operating Requirements Through 2021-End
Agile Therapeutics: Rises on U.S. launch of its FDA-approved contraceptive patch
Brief: Agile Therapeutics Announces Peer Reviewed Publication Of Phase 3 SECURE Study Results For Twirla Transdermal System In Contraception
Brief: Agile Therapeutics Reports Q3 2020 Financial Results
Brief: Agile Therapeutics Inc Files For Mixed Shelf Of Up To $200 Mln
Brief: Agile Therapeutics- Reaffirmed Its Previously Announced Operating Expense Guidance For Full Year 2020 To Be In Range Of $52 Mln To $56 Mln
Brief: Agile Therapeutics Reports Q2 Loss Per Share Of $0.12
Brief: Agile Therapeutics - Set Up Wholesale Acquisition Cost Of $159.75 For Treatment Cycle Of Twirla Transdermal System
Brief: Agile Therapeutics To Join Russell 3000 And 2000 Indexes
Brief: Agile Therapeutics Reports First Quarter 2020 Financial Results
Nasdaq Trade Halt Market Wide Circuit Breaker Halt: LEVEL 1 AT 08:35 AM
U.S. STOCKS ON THE MOVE-Apache, Alpha Pro Tech, Tesla, Gain Capital
U.S. STOCKS ON THE MOVE-Apache, Gain Capital, Virgin Galactic, U.S. airlines